Pharma Reviews: Quality, Not Price, is the Key Issue When Prescribing Generic Drugs in India

In the absence of a standard drug regulatory mechanism, Indian doctors rely on the reputation of companies who have demonstrated their commitment ...
Read more: Quality, Not Price, is the Key Issue When Prescribing Generic Drugs in India

Pharma Reviews: USFDA scrutiny of Indian pharma units up three-fold in 6 years

US Food and Drug Administration (USFDA) inspections at pharmaceutical units in India tripled between 2010 and 2015, says the Indian ...
Read more: USFDA scrutiny of Indian pharma units up three-fold in 6 years

Pharma Reviews: Hiring freeze in pharma sector as Centre pushes for generic medicine

On an average around 800-850 field sales staff are recruited by pharma companies across India every month, informed N Sivakumar, Business Head, ...
Read more: Hiring freeze in pharma sector as Centre pushes for generic medicine

Pharma Reviews: India Pharma Survey Reveals Digital Transformation Underway

Among Life Sciences Companies in India. (Attn.Editors: The following press release comes to you under an arrangement with PRNewswire. PTI takes ...
Read more: India Pharma Survey Reveals Digital Transformation Underway

Pharma Reviews: Sun Pharma Science Foundation recognizes Indian scientists & young research scholars

These Awards are presented annually to Indian scientists & young ... Shares of SUN PHARMACEUTICAL INDUSTRIES LTD. was last trading in BSE ...
Read more: Sun Pharma Science Foundation recognizes Indian scientists & young research scholars

Pharma Reviews: Indian pharma expects acceleration in hiring talent driven by new technology platforms and frenetic ...

Indian pharma industry expects accelerated growth in hiring talent during the current fiscal. The key factors for this are demand for candidates in sync ...
Read more: Indian pharma expects acceleration in hiring talent driven by new technology platforms and frenetic ...

Pharma Reviews: India to make molecules to cut dependency on China

The Indian pharmaceutical sector, which is dependent on import of crucial items such as APIs, is planning to manufacture a few of the top 100 ...
Read more: India to make molecules to cut dependency on China

US FDA News: FDA approves new combination treatment for acute myeloid leukemia

The U.S. Food and Drug Administration today approved Rydapt (midostaurin) for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) who have a specific genetic mutation called FLT3, in combination with chemotherapy. The drug is approved for use with a companion diagnostic, the LeukoStrat CDx FLT3 Mutation Assay, which is used to detect the FLT3 mutation in patients with AML.
Read more: FDA approves new combination treatment for acute myeloid leukemia

Pharma Reviews: The Digital Waves Hit India's Pharma Industry

Pharmaceutical companies in India, that were slower than their peers in technology adoption are bracing for a digital disruption in recent times.
Read more: The Digital Waves Hit India's Pharma Industry

Pharma Reviews: iPHEX 2017 pharma extravaganza kick starts in Hyderabad

iPHEX 2017, the 5th edition of Indian Pharmaceutical extravaganza has kick ... global showcase for the Indian pharmaceutical and healthcare sector.
Read more: iPHEX 2017 pharma extravaganza kick starts in Hyderabad

Pharma Reviews: India Pharma Survey Reveals Digital Transformation Underway Among Life Sciences Companies ...

A new industry survey by Veeva Systems reveals that pharmaceutical companies in India will leverage digital as a part of their strategy to achieve ...
Read more: India Pharma Survey Reveals Digital Transformation Underway Among Life Sciences Companies ...

Pharma Reviews: Pharmexcil move on acceptance of IP in Ghana

Adherence to IP would make it easier both in terms of time and cost for the Indian pharma companies, he said. If IP is accepted in Ghana, it would be a ...
Read more: Pharmexcil move on acceptance of IP in Ghana

Pharma Reviews: 'Ground being laid for Pharma City'

He urged Indian pharma companies to come and set up facilities in Ghana. Pharmexcil chairman Madan Mohan Reddy said over 580 overseas ...
Read more: 'Ground being laid for Pharma City'

Pharma Reviews: India to make molecules to cut dependency on China

Hyderabad: The Indian pharmaceutical sector, which is dependent on import of crucial items such as APIs, is planning to manufacture a few of the top ...
Read more: India to make molecules to cut dependency on China

Pharma Reviews: iPHEX, a major push to pharma exports

“India is a long term preferred partner for pharma supplies to Africa and we invite the Indian pharma industry to set up manufacturing units in Ghana ...
Read more: iPHEX, a major push to pharma exports

US FDA News: General Anesthetic and Sedation Drugs: Drug Safety Communication - FDA Approves Label Changes for Use in Young Children

Exposure to these medicines for lengthy periods of time or over multiple surgeries or procedures may negatively affect brain development in children younger than 3 years.
Read more: General Anesthetic and Sedation Drugs: Drug Safety Communication - FDA Approves Label Changes for Use in Young Children

US FDA News: FDA approves first treatment for a form of Batten disease

The U.S. Food and Drug Administration today approved Brineura (cerliponase alfa) as a treatment for a specific form of Batten disease. Brineura is the first FDA-approved treatment to slow loss of walking ability (ambulation) in symptomatic pediatric patients 3 years of age and older with late infantile neuronal ceroid lipofuscinosis type 2 (CLN2), also known as tripeptidyl peptidase-1 (TPP1) deficiency.
Read more: FDA approves first treatment for a form of Batten disease

US FDA News: FDA expands approved use of Stivarga to treat liver cancer

The U.S. Food and Drug Administration today expanded the approved use of Stivarga (regorafinib) to include treatment of patients with hepatocellular carcinoma (HCC or liver cancer) who have been previously treated with the drug sorafenib. This is the first FDA-approved treatment for a liver cancer in almost a decade.
Read more: FDA expands approved use of Stivarga to treat liver cancer

Pharma Reviews: Iphex begins in Hyderabad

Kwaku said, India is a long term preferred partner for pharma supplies to Africa and Ghana invites the Indian pharma industry to set up manufacturing ...
Read more: Iphex begins in Hyderabad

Pharma Reviews: Pharma City will boost growth in Hyderabad

Hyderabad: Hyderabad occupies a key place in the Indian pharmaceuticals sector with the city contributing 30 per cent of the nation's bulk drugs.
Read more: Pharma City will boost growth in Hyderabad

Pharma Reviews: Swiss pharma company faces probe for blocking cheaper cancer drugs

NEW DELHI: Antitrust regulator Competition Commission of India (CCI) has ordered a detailed investigation against Swiss drug maker Roche for ...
Read more: Swiss pharma company faces probe for blocking cheaper cancer drugs

Pharma Reviews: Indian pharma to maximise quality, timelines & budgets to market drug products via digital platforms

Indian pharma industry is increasingly opting to prepare the drug product branding with a mix of conventional and modern methods using digital ...
Read more: Indian pharma to maximise quality, timelines & budgets to market drug products via digital platforms

Pharma Reviews: For pharma's sake, drug regulatory agencies need to cooperate

The pharmaceutical Sector in India is at the crossroads. Having established itself as the world leader in the space of generics—accounting for one-fifth ...
Read more: For pharma's sake, drug regulatory agencies need to cooperate

Pharma Reviews: Move to make prescription of generics mandatory may kill Indian pharma industry, 9500 units will ...

In addition to this, there could be an all India shortage of all kinds of drugs. This step will force to close about 9,500 pharma industrial units from the ...
Read more: Move to make prescription of generics mandatory may kill Indian pharma industry, 9500 units will ...

US FDA News: Illegal Cancer Treatments: FDA Warning - Fraudulent Claims of Diagnosis, Treatment, Prevention or Cure

Use of unproven or unapproved products may be unsafe and could prevent a person from seeking an appropriate and potentially life-saving cancer diagnosis or treatment.
Read more: Illegal Cancer Treatments: FDA Warning - Fraudulent Claims of Diagnosis, Treatment, Prevention or Cure

US FDA News: FDA takes action against 14 companies for selling illegal cancer treatments

The U.S. Food and Drug Administration today posted warning letters addressed to 14 U.S.-based companies illegally selling more than 65 products that fraudulently claim to prevent, diagnose, treat or cure cancer. The products are marketed and sold without FDA approval, most commonly on websites and social media platforms.
Read more: FDA takes action against 14 companies for selling illegal cancer treatments

Pharma Reviews: Liquidity creating bubble in bond market; wary on NBFCs, like IT, pharma & auto: Ambit

Liquidity creating bubble in bond market; wary on NBFCs, like IT, pharma .... Being a contrarian in Indian market helps and we are least liquid of the ...
Read more: Liquidity creating bubble in bond market; wary on NBFCs, like IT, pharma & auto: Ambit

Pharma Reviews: Pharma companies discuss order on generic drugs

MUMBAI: Honchos of India's leading drug companies met on Monday evening in Ahmedabad to take stock of a recent diktat by the health ministry on ...
Read more: Pharma companies discuss order on generic drugs

Pharma Reviews: Three MNC pharma companies want to recall its new generation stents from India

Three MNC pharma companies want to recall its new generation stents from India MUMBAI: At least three multinational stent makers have filed ...
Read more: Three MNC pharma companies want to recall its new generation stents from India

Pharma Reviews: 3 Ways To Ensure Quality Products For Pharma Companies

India has always played a vital role when it comes to shaping future of global health care. In fact, India is the largest supplier of generic medicines ...
Read more: 3 Ways To Ensure Quality Products For Pharma Companies

US FDA News: 25 Percent Dextrose Injection, USP (Infant) by Hospira: Recall - Particulate Matter

Particulate administered to a patient could result in local swelling, irritation of blood vessels or tissue, blockage of blood vessels and/or systemic allergic response to the particulate.
Read more: 25 Percent Dextrose Injection, USP (Infant) by Hospira: Recall - Particulate Matter

Pharma Reviews: Tsunami of reform measures likely to hit the pharma stocks in the bourses

Indian pharmaceutical export is presently anchored by the US market and analysts believe that it will grow manifold within the coming few years.
Read more: Tsunami of reform measures likely to hit the pharma stocks in the bourses

Pharma Reviews: Three MNC pharma companies want to recall its new generation stents from India

In such case, our other drug eluting stents will remain available in India as per guidelines and norms set by the law," said the US company. NPPA told ...
Read more: Three MNC pharma companies want to recall its new generation stents from India

Pharma Reviews: `Chemists, and Not Doctors, Could Decide Brand of Drug Use'

Modi's proposal is seen as an attempt to bring expensive drugs to poor Indians, and also as a not-so-subtle swipe to regulate the doctor-drug company ...
Read more: `Chemists, and Not Doctors, Could Decide Brand of Drug Use'

Pharma Reviews: Simulations Plus inks distribution deal with Electrolab India

Simulations Plus, a leading provider of modeling and simulation software and consulting services for the pharmaceutical, biotechnology, and ...
Read more: Simulations Plus inks distribution deal with Electrolab India

Pharma Reviews: Drug pricing control regime adversely impacting pharma industry

He pointed out that in the last decade, Indian API manufacturers have become less competitive as compared to their counterparts in China primarily ...
Read more: Drug pricing control regime adversely impacting pharma industry

US FDA News: Phenobarbital 15 mg Tablets, USP by C.O. Truxton: Recall - Labeling Error on Declared Strength

Mislabeled product could expose the consumer or their pet(s) to potential overdosing that can cause severe intoxication which may lead to cardiogenic shock, renal failure, coma or death.
Read more: Phenobarbital 15 mg Tablets, USP by C.O. Truxton: Recall - Labeling Error on Declared Strength

Pharma Reviews: Intellectual Property Rights: Building or Stumbling Blocks? – On The Right Track

This could not be more true than for the pharmaceutical industry. With the Indian pharmaceutical industry en route to becoming a major player in the ...
Read more: Intellectual Property Rights: Building or Stumbling Blocks? – On The Right Track

Pharma Reviews: Indian government may ask doctors to prescribe medicines under generic names. Is it practical?

The proposal has generated a heated conversation in the media and in the pharma industry. Generics are medicines on which patents have expired.
Read more: Indian government may ask doctors to prescribe medicines under generic names. Is it practical?

Pharma Reviews: Indian pharma no longer a growth tonic for FIIs

MUMBAI: Saddled with heightened USFDA scrutiny, a strong rupee, weak commercial potential of drugs in the pipeline, the Indian pharmaceutical ...
Read more: Indian pharma no longer a growth tonic for FIIs

Pharma Reviews: Indian Pharmaceutical Alliance urges health ministry to take industry into confidence on regulating ...

The Indian Pharmaceutical Alliance, a representative body of 20 research based pharmaceutical companies in the country, expressing concern over ...
Read more: Indian Pharmaceutical Alliance urges health ministry to take industry into confidence on regulating ...

US FDA News: FDA statement from Douglas Throckmorton, M.D., deputy center director for regulatory programs, Center for Drug Evaluation and Research, on new warnings about the use of codeine and tramadol in children & nursing mothers

The health and safety of children is a top priority at the FDA, which is why today we are requiring a series of changes to the labeling of two types of opioid medications in order to help better protect children from serious risks associated with these medicines – codeine (found in some prescription pain and cough medicines and some over-the-counter cough medicines) and tramadol (found in some prescription pain medicines).
Read more: FDA statement from Douglas Throckmorton, M.D., deputy center director for regulatory programs, Center for Drug Evaluation and Research, on new warnings about the use of codeine and tramadol in children & nursing mothers

US FDA News: Codeine and Tramadol Medicines: Drug Safety Communication - Restricting Use in Children, Recommending Against Use in Breastfeeding Women

New and strengthened WARNINGS and CONTRAINDICATIONS on drug labels describing serious risks, including slowed or difficult breathing and death.
Read more: Codeine and Tramadol Medicines: Drug Safety Communication - Restricting Use in Children, Recommending Against Use in Breastfeeding Women

Pharma Reviews: CDSCO to audit manufacturing units globally, upgrade Sch M units domestically towards drug quality

The industry has strong capabilities in product development. Also, Indian pharmaceutical companies have the largest share of DMFs and ANDAs ...
Read more: CDSCO to audit manufacturing units globally, upgrade Sch M units domestically towards drug quality

Pharma Reviews: Foreign Direct Investment in pharmas boon or bane?

One such field is Pharmaceuticals. Already the Indian Pharmaceutical giants have proved their might in exploring and exploiting the newer markets for ...
Read more: Foreign Direct Investment in pharmas boon or bane?

Pharma Reviews: Mandatory code for doctors to ensure generics get precedence over branded drugs

The Uniform Code for Pharmaceutical Marketing Practices (UCPMP) will be legally binding on all stakeholders through an executive order. ... DoP has already consulted health ministry and Medical Council of India on the decision.
Read more: Mandatory code for doctors to ensure generics get precedence over branded drugs

Pharma Reviews: Piramal Enterprises Partners with Indian Pharmaceutical Association to Educate Stakeholders on ...

Piramal Enterprises' Consumer Products business has partnered with the Indian Pharmaceutical Association (IPA), to promote responsible self-care to ...
Read more: Piramal Enterprises Partners with Indian Pharmaceutical Association to Educate Stakeholders on ...

US FDA News: Organic Herbal Supply Supplement Products: Recall - Undeclared Drug Ingredients

Use of these products may pose a threat to consumers because the undeclared ingredients may interact with nitrates found in some prescription drugs and may lower blood pressure to dangerous levels.
Read more: Organic Herbal Supply Supplement Products: Recall - Undeclared Drug Ingredients

Pharma Reviews: THE API CHALLENGE

Indian pharmaceutical industry, a highly export oriented sector of the country, is facing a serious challenge to its survival in the coming years if its ...
Read more: THE API CHALLENGE

Pharma Reviews: PM's push for generic drugs to shift focus to chemists, says pharma industry body

The Indian Pharmaceutical Alliance (IPA) said that due to the nature of the current off-patent medicines market in India, if such a step were to be ...
Read more: PM's push for generic drugs to shift focus to chemists, says pharma industry body

Pharma Reviews: Modi govt plan on generic drugs makes pharma companies, doctors jittery

Some industry veterans view this from the angle of marketing ethics. Veeramani, formerly the president of the Indian Drug Manufacturers' Association ...
Read more: Modi govt plan on generic drugs makes pharma companies, doctors jittery

Pharma Reviews: A new law to make docs prescribe generics? PM Modi hints as much

Industry bodies like Indian Pharmaceutical Alliance are concerned by the move on grounds that it empowers chemists over the doctor to decide which ...
Read more: A new law to make docs prescribe generics? PM Modi hints as much

Pharma Reviews: Pharma industry waiting for CDSCO's revised post marketing surveillance guidelines

The draft notification on post marketing surveillance of pharmaceutical products in India was issued by Union health ministry on March 8, 2016 ...
Read more: Pharma industry waiting for CDSCO's revised post marketing surveillance guidelines

Pharma Reviews: Pharmaceutical Industry: 'It's refreshing to see administration responding to its citizens'

On April 13, the Indian Pharmaceutical Alliance (IPA), through its general secretary, published an op-ed criticising the current government's ...
Read more: Pharmaceutical Industry: 'It's refreshing to see administration responding to its citizens'

Pharma Reviews: Life sciences and healthcare space to see M&A boom in 2017

The Indian pharmaceutical market stood at around $39.5 billion in FY2015-16 and is expected to grow at a rapid pace. Accelerated consolidation is ...
Read more: Life sciences and healthcare space to see M&A boom in 2017

Pharma Reviews: Only a ministry for pharma can save SMEs in this sector: President IDMA

Therefore, the government should consider formation of a separate ministry for pharmaceuticals. If it happens, Indian pharma sector will prosper well ...
Read more: Only a ministry for pharma can save SMEs in this sector: President IDMA

Pharma Reviews: Indian drug regulator plans to inspect firms abroad, like FDA

In fact, last year nine warning letters were issued to Indian pharma companies exporting to the US. Several plants of top drug makers in India have ...
Read more: Indian drug regulator plans to inspect firms abroad, like FDA

Pharma Reviews: Rising rupee another risk for Indian pharma

Pricing pressure and regulatory issues are not the only thing worrying executives of Indian pharmaceuticals' companies. Weakening of the dollar ...
Read more: Rising rupee another risk for Indian pharma

Pharma Reviews: Sun Pharma, Torrent, DRL & Lupin CLSA's top pharma picks

With rapid price deterioration in the simple generics industry in the US, Indian pharma companies are in a challenging situation. But at the same time, ...
Read more: Sun Pharma, Torrent, DRL & Lupin CLSA's top pharma picks

Pharma Reviews: Opportunity for India as Venezuela seeks UN help to buy pharmaceutical products

Venezuela has reached out to the UN to help it buy pharmaceutical products, offering India an opportunity to supply vital drugs to the cash-strapped ...
Read more: Opportunity for India as Venezuela seeks UN help to buy pharmaceutical products

Pharma Reviews: India's oldest pharma company makes profit after six decades

It's history in all senses of the word. Set up as an individual initiative in a laboratory in 1892 by the 'father of Indian chemistry' Acharya Prafulla ...
Read more: India's oldest pharma company makes profit after six decades

Pharma Reviews: Pharma body working to slash imports

The Pharmaceuticals Export Promotion Council of India (Pharmexcil), under the ministry of commerce and industry, is working on a zero dependant ...
Read more: Pharma body working to slash imports

Pharma Reviews: Pharmexcil's IPHEX exhibition comes to city

Events like IPHEX serve as a forum highlighting the capabilities of Indian pharmaceutical industry — already a major supplier of generic drugs globally ...
Read more: Pharmexcil's IPHEX exhibition comes to city

US FDA News: FDA allows marketing of first whole slide imaging system for digital pathology

The U.S. Food and Drug Administration today permitted marketing of the Philips IntelliSite Pathology Solution (PIPS), the first whole slide imaging (WSI) system that allows for review and interpretation of digital surgical pathology slides prepared from biopsied tissue. This is the first time the FDA has permitted the marketing of a WSI system for these purposes.
Read more: FDA allows marketing of first whole slide imaging system for digital pathology

Pharma Reviews: Pharma exports likely slid to $16.4 billion in 2016-17

India's pharmaceutical exports are projected to have declined marginally in the financial year ended March 31, 2017, after clocking more than 9% ...
Read more: Pharma exports likely slid to $16.4 billion in 2016-17

Pharma Reviews: India asks US to relax norms for greater access to mangoes

New Delhi, Apr 12 (PTI) India has asked the US to relax certain norms ... She also said that "Indian pharma companies are subject to unwarranted and ...
Read more: India asks US to relax norms for greater access to mangoes

Pharma Reviews: Indian pharmaceutical exports to reach USD 20 billion next three years: Uday Bhaskar

Indian Pharmaceutical exports will reach USD 20 billion during next three years with a growth rate of 30 per cent, Pharmexil, Director General Uday ...
Read more: Indian pharmaceutical exports to reach USD 20 billion next three years: Uday Bhaskar

Pharma Reviews: Indian drug market grows at 9.6% in March on waning demonetisation effect

The Indian pharmaceutical market (IPM) grew at a much better pace in March led by improved sales of drugs in chronic segment and acute segment ...
Read more: Indian drug market grows at 9.6% in March on waning demonetisation effect

Pharma Reviews: Indian pharma market clocks growth of 9.6% in March 2017

Indian pharmaceutical market has registered a sales growth of 9.6 per cent at Rs. 8,989 crore for the month of March 2017, which is much higher than ...
Read more: Indian pharma market clocks growth of 9.6% in March 2017

US FDA News: FDA approves first drug to treat tardive dyskinesia

The U.S. Food and Drug Administration today approved Ingrezza (valbenazine) capsules to treat adults with tardive dyskinesia. This is the first drug approved by the FDA for this condition.
Read more: FDA approves first drug to treat tardive dyskinesia

Pharma Reviews: Winning strategies for companies to succeed in ever-changing pharma market

Move up the value chain through research and development (R&D): Over the last two decades, Indian pharmaceutical companies have acquired ...
Read more: Winning strategies for companies to succeed in ever-changing pharma market

Pharma Reviews: Industry bodies want separate ministry for pharma, shifting of NPPA, DoP to health ministry

“We have all along been demanding for a separate Ministry of Pharmaceuticals (MoP) considering the current status of the Indian pharma industry in ...
Read more: Industry bodies want separate ministry for pharma, shifting of NPPA, DoP to health ministry

Pharma Reviews: Hurt by competition, price caps, drug firms turn to in-licencing

Among leading Indian companies that have signed such in-licensing deals are Sun Pharma, Lupin, Dr Reddy's Labs and Glenmark Pharma.
Read more: Hurt by competition, price caps, drug firms turn to in-licencing

Pharma Reviews: Deepnath Roy Chowdhury takes over as IDMA national president

We hope to set up state boards and inspire more companies to join IDMA family to further strengthen the Indian Pharmaceutical Industry's march ...
Read more: Deepnath Roy Chowdhury takes over as IDMA national president

Pharma Reviews: India capable of much more growth than it has delivered: Hugh Young

I think it is a challenge for Indian pharma and the industry has underperformed. As a result, growth has slowed down and maybe this comes back to ...
Read more: India capable of much more growth than it has delivered: Hugh Young

Pharma Reviews: Golden days for Pharma, IT are over: Hugh Young of Aberdeen Asset Management

It is a challenge for Indian pharma industry that has clearly underperformed. As a result, growth has slowed and maybe this comes back to what I was ...
Read more: Golden days for Pharma, IT are over: Hugh Young of Aberdeen Asset Management

US FDA News: StrataMR Adjustable Valves and Shunts by Medtronic: Recall - Potential for Under-Drainage of Cerebrospinal Fluid

If left untreated, under-drainage can potentially lead to coma and death.
Read more: StrataMR Adjustable Valves and Shunts by Medtronic: Recall - Potential for Under-Drainage of Cerebrospinal Fluid

Pharma Reviews: India, Egypt should strengthen cooperation in pharmaceuticals

Cairo, Apr 8 (PTI) Egypt should strengthen its cooperation in pharmaceutical sector with India which has great advantages in terms of providing ...
Read more: India, Egypt should strengthen cooperation in pharmaceuticals

Pharma Reviews: USFDA sounds alert on quality issues in Indian pharma

Quality is a challenge for the Indian pharmaceutical sector, the largest supplier of drugs to the United States, according to a recent blog by the US ...
Read more: USFDA sounds alert on quality issues in Indian pharma

Pharma Reviews: India, Egypt should strengthen cooperation in pharmaceuticals

cairo, Apr 8 Egypt should strengthen its cooperation in pharmaceutical sector with India which has great advantages in terms of providing affordable ...
Read more: India, Egypt should strengthen cooperation in pharmaceuticals

Pharma Reviews: Weak growth in US business to hit Indian pharma sector

We expect another muted quarter for the pharma sector on the back of weak growth in US business due to competition and pricing erosion.
Read more: Weak growth in US business to hit Indian pharma sector

Pharma Reviews: Two-Day International Conference of Pharmacy (ICP-2017) inaugurated at LPU Campus

Dr. Umesh Banakar from USA, Vice-Chairman of the Confederation of Indian Pharmaceutical Industry Dr T.C. Kansal, Secretary SPER Dr. Upendra ...
Read more: Two-Day International Conference of Pharmacy (ICP-2017) inaugurated at LPU Campus

US FDA News: FDA approves two hepatitis C drugs for pediatric patients

The U.S. Food and Drug Administration today approved supplemental applications for Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) to treat hepatitis C virus (HCV) in children ages 12 to 17. Harvoni and Sovaldi were previously approved to treat HCV in adults.
Read more: FDA approves two hepatitis C drugs for pediatric patients

Pharma Reviews: Indian pharma brace to scout for digital marketing personnel to engage with clinicians & consumers

Indian pharma companies are currently facing a dual challenge of hiring and creating a digital marketing sales team. On the one hand the companies ...
Read more: Indian pharma brace to scout for digital marketing personnel to engage with clinicians & consumers

Pharma Reviews: Indian pharma cos get 55 final ANDA approvals from US FDA in Q1 of 2017

Higher investments in R&D during last couple of years has started yielding good results for R&D based Indian phrma companies in current year.
Read more: Indian pharma cos get 55 final ANDA approvals from US FDA in Q1 of 2017

Pharma Reviews: Affordable healthcare: Govt to review existing drug price control measures

Earlier, expressing concern over future of the pharma industry in India, the Indian Pharmaceutical Alliance (IPA) had said pharma companies have ...
Read more: Affordable healthcare: Govt to review existing drug price control measures

US FDA News: Sterile Compounded Products by Isomeric Pharmacy Solutions: Recall - Lack of Sterility Assurance

Voluntary recall of all lots of sterile products, to the hospital/user level.
Read more: Sterile Compounded Products by Isomeric Pharmacy Solutions: Recall - Lack of Sterility Assurance

US FDA News: FDA allows marketing of first direct-to-consumer tests that provide genetic risk information for certain conditions

The U.S. Food and Drug Administration today allowed marketing of 23andMe Personal Genome Service Genetic Health Risk (GHR) tests for 10 diseases or conditions. These are the first direct-to-consumer (DTC) tests authorized by the FDA that provide information on an individual’s genetic predisposition to certain medical diseases or conditions, which may help to make decisions about lifestyle choices or to inform discussions with a health care professional.
Read more: FDA allows marketing of first direct-to-consumer tests that provide genetic risk information for certain conditions

Pharma Reviews: India needs to make it mandatory for drug firms to have pharmacovigilance audit for patient safety ...

India needs to make it mandatory for pharmaceutical companies to have pharmacovigilance (PV) audit to ensure patient safety and good ...
Read more: India needs to make it mandatory for drug firms to have pharmacovigilance audit for patient safety ...

Pharma Reviews: Health Ministry may soon house NPPA, Department of Pharmaceuticals

In February this year, in a curt letter to Niti Ayog vice chairman Arvind Panagariya, the Indian Pharmaceutical Alliance (IPA), the lobby group of top ...
Read more: Health Ministry may soon house NPPA, Department of Pharmaceuticals

Pharma Reviews: Turf War

One factor that has always bothered the Indian pharmaceutical industry is the presence of too many governing and regulatory bodies. Rationalising ...
Read more: Turf War

US FDA News: Newport HT70 and HT70 Plus Ventilators by Medtronic: Field Corrective Action - Ventilator May Reset Spontaneously

Potential for ventilator reset during normal operation, without an accompanying alarm.
Read more: Newport HT70 and HT70 Plus Ventilators by Medtronic: Field Corrective Action - Ventilator May Reset Spontaneously

Pharma Reviews: Battleground US

What these examples illustrate is how the competitive landscape is changing in the US for major Indian pharma companies. In many cases, the ...
Read more: Battleground US

Pharma Reviews: PMO is closely watching prices of drugs, stents and other controlled products: DCGI

He said this while speaking at the 'technical seminar' organised by the Madhya Pradesh state branch of the Indian Pharmaceutical Association (IPA) ...
Read more: PMO is closely watching prices of drugs, stents and other controlled products: DCGI

Pharma Reviews: Indian Pharmaceutical Alliance punches holes into drug pricing policy implementation

A body of major domestic pharma firms, IPA has hit out at the government over drug price control issue, wondering if the country followed rule of law ...
Read more: Indian Pharmaceutical Alliance punches holes into drug pricing policy implementation

Pharma Reviews: UK-India to hold talks on bilateral trade, investment

Expressing concern about future of the pharma industry in India, the Indian Pharmaceutical Alliance (IPA) said pharma companies have become […].
Read more: UK-India to hold talks on bilateral trade, investment

Pharma Reviews: Negative growth in pharma exports

Hyderabad: India's pharmaceutical exports during April-Feb (2016-17) has experienced a negative growth of 1 per cent over the corresponding period ...
Read more: Negative growth in pharma exports

Pharma Reviews: Has the Indian pharmaceutical sector become a soft target?

The last one year has witnessed more than 400 Indian and foreign pharmaceutical companies going to the courts to resolve their grievances. Almost ...
Read more: Has the Indian pharmaceutical sector become a soft target?